J. Cline to Mammary Neoplasms, Experimental
This is a "connection" page, showing publications J. Cline has written about Mammary Neoplasms, Experimental.
Connection Strength
0.579
-
Cline JM, Wood CE. Hormonal effects on the mammary gland of postmenopausal nonhuman primates. Breast Dis. 2005-2006; 24:59-70.
Score: 0.244
-
Davis VL, Shaikh F, Gallagher KM, Villegas M, Rea SL, Cline JM, Hughes CL. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ER?3, a dominant negative estrogen receptor a variant. Horm Cancer. 2012 Dec; 3(5-6):227-39.
Score: 0.104
-
Johnson NA, Ho A, Cline JM, Hughes CL, Foster WG, Davis VL. Accelerated mammary tumor onset in a HER2/Neu mouse model exposed to DDT metabolites locally delivered to the mammary gland. Environ Health Perspect. 2012 Aug; 120(8):1170-6.
Score: 0.101
-
Sikoski P, Trybus J, Cline JM, Muhammad FS, Eckhoff A, Tan J, Lockard M, Jolley T, Britt S, Kock ND. Cystic mammary adenocarcinoma associated with a prolactin-secreting pituitary adenoma in a New Zealand white rabbit (Oryctolagus cuniculus). Comp Med. 2008 Jun; 58(3):297-300.
Score: 0.077
-
Ramsey MM, Ingram RL, Cashion AB, Ng AH, Cline JM, Parlow AF, Sonntag WE. Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis. Endocrinology. 2002 Oct; 143(10):4139-42.
Score: 0.052